Difference between revisions of "IVAX Corporation"

From Powerbase
Jump to: navigation, search
(→‎People)
Line 6: Line 6:
 
*[[Isaac Kaye]]
 
*[[Isaac Kaye]]
  
−
In 2003, the following people are reported as serving IVAX<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>...
+
In 2003, the following people are reported as serving IVAX...
−
* [[Dan Weiner]] - Senior Vice President for Global Clinical Development
+
* [[Frank Condella]] - Managing Director in the UK <ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
−
* [[Steve Marcus]] - Senior Vice President for Proprietary Pharmaceutical Business Development.
+
* [[Dan Weiner]] - Senior Vice President for Global Clinical Development<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>
−
* [[Nick Vodar]] - Director of Drug Discovery and the Director of IVAx's Institute for Drug Research in Budapest, Hungary.
+
* [[Steve Marcus]] - Senior Vice President for Proprietary Pharmaceutical Business Development<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>.
−
* [[Betty Amos]] - Board member
+
* [[Nick Vodar]] - Director of Drug Discovery and the Director of IVAx's Institute for Drug Research in Budapest, Hungary<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>.
−
* [[Mitch Medique]] - Board member. Medique also serves on the board of several public companies (including [[National Semiconductor]] and [[Carnival Corporations]]).
+
* [[Betty Amos]] - Board member. Amos is the owner and president of The [[Abkey Companies]] and a franchisee of [[Fuddruckers]] restaurants<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>.
−
* [[Burt Pitt]]. Pitt is also a professor of cardiology at the University of Michigan School of Medicine.
+
* [[Mitch Medique]] - Board member. Medique also serves on the board of several public companies (including [[National Semiconductor]] and [[Carnival Corporations]])<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>. He is also a past chairman of The [[Beacon Council]] (Miami's economic development authority)<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Burt Pitt]]. Pitt is also a professor of cardiology at the University of Michigan School of Medicine<ref><i>FD (Fair Disclosure) Wire</i> 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003</ref>.
 +
* [[Philip Frost]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Neil Flanzraich]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Jane Hsiao]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Mark Andrews]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Ernst Biekert]]- Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Jack Fishman]]- Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[Richard Pfenniger]] Jr. - Board member <ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
 +
* [[David Lieberman]] - Board member<ref><i>Company News</i> 'IVAX Corporation - Directorate Change'. 22nd April 2003</ref>
  
 
==Aquisitions and Partnerships==
 
==Aquisitions and Partnerships==

Revision as of 13:49, 4 June 2008

The Ivax Corporation is a huge Florida-based health company. Norton Healthcare, the largest generic drugs company in Britain, is a subsidiary of IVAX. Isaac Kaye earned $550,301 at IVAX in 1998 (plus share options worth up to $1.5 million) and $521,520 in 1997.[1]. In 2006 IVAX was aquired by Teva which is described as 'Israel's largest company'.[2] The aquisition is reported to have created 'the world's largest generics company'.[3].

Kaye is reported to have stepped down as chairman of Norton Healthcare in 2003[4]. Plunkett's Health Care Industry Almanac reports IVAX profits totalling $243,200,000 for 2001, $131,000,000 for 2000 and $70,700,000 for 1999. Their sales totals were $1,215,400,000, $793,400,000, and $656,500,000 respectively.

People

In 2003, the following people are reported as serving IVAX...

Aquisitions and Partnerships

In 2004, IVAX is reported to have aquired ChemSource Corporation (which is based in Puerto Rico)[21] .

ChemSource is reported to have 'recently entered into a license agreement with Novartis Pharma AG to utilize the patented multi-dose dry powder inhaler, Airmax, for Novartis's trademarked medicines Foradil and Miflonide in the European Union and certain other countries'[22].

In 2002, it is reported that IVAX 'established a company in France by acquiring Merck Sharp & Dohme's portfolio of generic products there[23].

Litigation

In July 2003, Business Wire reports that IVAX 'received the first of a series of payments from B Braun Melsungen AG, under a number of agreements, for certain patent and product rights and for settlement of litigation'[24]. No further details were disclosed.

In 2003, Thomas Beier, Senior Vice President and Chief Financial Officer for IVAX reported 'Operating expenses' which included a $6.6 million legal settlement[25]. No further details were disclosed.

Brands, Divisions and Affiliates

In 2004, Plunkett's Health Care Industry Almanac reports the following 'Brands/Divisions/Affiliates' of IVAX[26]...

References

  1. ↑ Ref needed
  2. ↑ Teva, IVAX Acquisition, accessed 23 May 2008
  3. ↑ Maguire K (2002) Profile:Isaac Kaye The Guardian 13th April 2002. Accessed 4th April 2008
  4. ↑ Brogan, B. & Gysin, C. (2008) Hain faces sack in sleaze inquiry; He could be barred - but Brown might fire him first. The Daily Mail (London). 12th January 2008
  5. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  6. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  7. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  8. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  9. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  10. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  11. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  12. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  13. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  14. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  15. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  16. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  17. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  18. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  19. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  20. ↑ Company News 'IVAX Corporation - Directorate Change'. 22nd April 2003
  21. ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
  22. ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
  23. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  24. ↑ Business Wire 'IVAX Reports Increased Revenues and Net Income for 2nd Quarter of 2003; 2Q2003 Net Revenues Up 22% to $343 Million, Net Income Up 30% to $41.3 Million' 30th July 2003. Miami
  25. ↑ FD (Fair Disclosure) Wire 'Q1 2003 Ivax Earnings Conference Call - Final'. 24th April 2003
  26. ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
Retrieved from "https://powerbase.info/index.php?title=IVAX_Corporation&oldid=60819"